The glycosylphosphatidylinositol (GPI) anchor is a C-terminal posttranslational modification found on many eukaryotic proteins that reside in the outer leaflet of the cell membrane. The complex and diverse structures of GPI anchors suggest a rich spectrum of biological functions, but few have been confirmed experimentally because of the lack of appropriate techniques that allow for structural perturbation in a cellular context. We previously synthesized a series of GPI anchor analogs with systematic deletions within the glycan core and coupled them to the GFP by a combination of expressed protein ligation and native chemical ligation Here we investigate the behavior of these GPI-protein analogs in living cells. These modified proteins integrated into the plasma membranes of a variety of mammalian cells and were internalized and directed to recycling endosomes similarly to GFP bearing a native GPI anchor. The GPI-protein analogs also diffused freely in cellular membranes. However, changes in the glycan structure significantly affected membrane mobility, with the loss of monosaccharide units correlating to decreased diffusion. Thus, this cellular system provides a platform for dissecting the contributions of various GPI anchor components to their biological function. cellular diffusion ͉ glycosylphosphatidylinositol-protein analogs ͉ intracellular trafficking ͉ GFP-GPI ͉ GPI glycan core
T
he glycosylphosphatidylinositol (GPI) anchor is a ubiquitous posttranslational modification that was characterized Ͼ15 years ago but still remains a mystery with respect to its biological function (1) (2) (3) (4) (5) (6) . Positioned at the C terminus of many eukaryotic proteins, the GPI anchor provides a means to attach those proteins to the outer leaflet of the cell membrane. Unlike simple lipid modifications, such as prenyl, palmitoyl, and myristoyl groups, the GPI anchor is a complex structure comprising a phosphoethanolamine linker, glycan core, and phospholipid tail ( Fig. 1A) (1, 2) . The phosphoinositol, glucosamine, and mannose residues within the glycan core can be variously modified with phosphoethanolamine groups and other sugars (1, (7) (8) (9) . Such complexity would be expected to encode diverse functional capability beyond membrane insertion (2, 10, 11) . Indeed, several studies have implicated the GPI anchor in targeting to lipid rafts, specific intracellular compartments, or the apical membrane of polarized epithelial cells (12) (13) (14) (15) (16) (17) (18) (19) (20) . Still others have suggested a role in transmembrane signaling (21) (22) (23) . However, definitive conclusions that relate GPI anchor structure and function have been difficult to draw. When produced in cells, GPI-anchored proteins exist as heterogeneous mixtures with considerable variation in their glycan core modifications and lipid moieties, a complicating feature with respect to functional analysis (1, (7) (8) (9) . Furthermore, well defined modifications to the GPI anchor structure cannot be imposed by using conventional biological methods; the biosynthetic enzymes are not well characterized, and their disruption in cells simply leads to loss of the entire GPI structure (24) (25) (26) (27) (28) (29) .
Chemical synthesis offers a powerful alternative to biosynthesis for generating proteins bearing posttranslational modifications. The process ensures homogeneity of the modification and provides access to structural variants. Solid-phase peptide synthesis, combined with native chemical ligation (NCL), has been used to generate a number of smaller posttranslationally modified proteins (30, 31) . The technique of expressed protein ligation (EPL) allows convergent assembly of larger recombinant protein fragments and synthetic moieties and has been widely applied to the generation of proteins with both natural and unnatural modifications (32) (33) (34) (35) (36) . These frontier synthetic methods now enable modulation of protein structures for functional analysis in a cellular context. Our understanding of the Ras signaling pathway in differentiating cells has been enhanced by the availability of synthetically modified lipoprotein analogs (37) .
With the aim of defining the functional significance of the GPI glycan core, we recently synthesized a series of GPI anchor analogs bearing systematic modifications to the core structure (38) . In these analogs, the conserved glycan core was replaced with poly(ethylene glycol) spacers possessing no monosaccharides (2), one mannosyl unit (3), or two mannosyl units (4) (Fig.  1 A) . The GPI analog structures were designed to mimic the overall length of the native GPI anchor. Addition of a cysteine residue to the phosphoethanolamine linker situated the analogs for NCL with recombinant GFP, which were C-terminally activated by EPL (Fig. 1B) (38) . Here we investigate the biological behavior of these GPI-protein analogs in living cells. After demonstrating that these modified proteins integrate into mammalian cell membranes, we then compared their intracellular trafficking to GFP bearing a native GPI anchor. Finally, we analyzed the cellular diffusion properties of the GPI-protein analogs, ultimately finding that the monosaccharides of the glycan core affect membrane mobility.
Results

GFP-2, GFP-3, and GFP-4 Incorporate into Mammalian Cell Membranes.
Previous studies have established that native GPI-anchored proteins, such as decay-accelerating factor (DAF) (39, 40) and CD59 (41) , can be inserted into mammalian cell membranes by simple exogenous addition. Generally, exogenously added GPIanchored proteins retain the same characteristics and functions as their endogenously expressed congeners (39) (40) (41) (42) . Therefore, we adopted the same approach to incorporate the modified proteins, GFP-2, GFP-3, and GFP-4, onto cell membranes with minimal perturbation to the cells.
We evaluated the incorporation of GFP-2, GFP-3, and GFP-4 onto both adherent and nonadherent cells derived from various tissues. The cell lines chosen were COS-7, HeLa, HEK293, CHO, and Jurkat. Cells were incubated with 10 g of GFP-2, GFP-3, or GFP-4 for 3 h at 37°C in reduced-serum or serum-free media and analyzed by flow cytometry. As a negative control, we generated a GFP variant (GFP-Cys), in which a simple cysteine residue was ligated to the protein derived from the intein fusion. Lacking any lipid moieties, GFP-Cys was not expected to associate with cell membranes. All of the cell lines incubated with GFP-2, GFP-3, or GFP-4 showed a 5-to 10-fold increase in fluorescence, compared with cells treated with vehicle (PBS ϩ 0.05% ␤-octyl glucoside) or GFP-Cys [ Fig. 2 and supporting information (SI) Fig. 6 ]. Notably, the use of serum-free or reduced-serum media was critical for these experiments. Media containing normal levels of serum were found to inhibit the incorporation of the modified GFPs onto cell membranes possibly because of an interaction of the lipid-modified GFPs with specific serum proteins. These data suggest that GFPs containing a chemically modified GPI anchor incorporate into mammalian cell surface membranes. Importantly, cells treated with GFP-Cys exhibited identical fluorescence to cells treated with vehicle, indicating that attachment of a GPI anchor analog is required for insertion into membranes.
We next studied the dose and time dependence of membrane association. HeLa cells were treated with 0.05-10 g/ml GFP-2, GFP-3, or GFP-4 for 4 h at 37°C and analyzed by flow cytometry (SI Fig. 7) . A large increase in fluorescence intensity was observed upon addition of 1 g/ml modified GFPs to HeLa cells, with saturation occurring at 5 g/ml protein. To determine the optimal incubation time, HeLa cells were treated with 5 g/ml GFP-2, GFP-3, or GFP-4 for 20 min to 12 h in serum-free media. Flow-cytometry analysis showed robust incorporation of GFP-2, GFP-3, and GFP-4 after only 20 min (SI Fig. 8 ). Higher levels of fluorescence were obtained after longer incubation times, but the mean fluorescence intensities (MFIs) for all of the modified GFPs leveled off after 8 h of incubation. Based on these observations, subsequent experiments were performed by using 5-10 g/ml protein for an incubation time of at least 4 h. GPI-anchored proteins, like all cell surface proteins, are subject to internalization, down-regulation, and degradation. GPIanchored proteins have been found in a variety of endosomes, suggesting multiple paths of internalization for these proteins (15) (16) (17) (18) (43) (44) (45) . In CHO cells, endogenous GPI-anchored proteins, as well as a GPI-anchored version of GFP (GFP-GPI), have been found to traffic to the GPI-anchored protein-enriched endosomal compartment and then to the recycling endosomes (15, 18, (43) (44) (45) . To study the effects of glycan core modifications on the endocytic fate of GPI-anchored proteins, the intracellular trafficking of exogenously added GFP-2, GFP-3, and GFP-4 in CHO cells was investigated by using fluorescence microscopy. For comparative purposes, we investigated the intracellular trafficking of endogenously expressed GFP bearing a native GPI anchor. These studies were conducted by using previously described constructs in which GFP was fused to the C-terminal signal peptide derived from either DAF [GFP-GPI(DAF)] (46) or the folate receptor [GFP-GPI(FR)] (16). CHO cells were incubated with GFP-2, GFP-3, GFP-4, or GFP-Cys and then treated with either dextran-Alexa Fluor 647 (Dex-647) to visualize early endosomes or transferrin-Alexa Fluor 647 (Tf-647), a marker for recycling endosomes. As with native GPI-anchored proteins, GFP-2, GFP-3, and GFP-4 were found largely on the CHO cell surface (Fig. 3) . However, detectable GFP fluorescence was observed inside the cells, suggesting that the GPIprotein analogs were internalized. Intracellular GFP-2, GFP-3, and GFP-4 showed no colocalization with Dex-647, signifying that the modified proteins did not accumulate in early endosomes of CHO cells (SI Fig. 9 ). However, internalized GFP-2, GFP-3, and GFP-4 showed substantial colocalization with Tf-647, indicating that the modified GFPs accumulated in the recycling endosomes (Fig. 3) . CHO cells incubated with GFPCys showed no detectable fluorescence from GFP (SI Fig. 10 ). CHO cells transiently transfected with DNA encoding GFP-GPI(DAF) or GFP-GPI(FR) also were analyzed by fluorescence microscopy. After 48 h, the cells were treated with Dex-647 or Tf-647 and imaged by fluorescence microscopy. As seen with GFP-2, GFP-3, and GFP-4, most of the GFP fluorescence for both GFP-GPIs was found on the CHO cell surface. Low levels of GFP fluorescence were observed inside the cells, coincident with Tf-647, but not with Dex-647 ( Fig. 3 and SI Fig. 9 ). Thus, as previously reported, natively anchored GFP-GPI accumulated in the recycling endosomes of CHO cells (15) . However, in contrast to previous reports, we did not observe substantial colocalization of GFP-GPI and Dex-647 (15).
Mobilities of GFP-2, GFP-3, and GFP-4 on HeLa Cell Surfaces. Many native GPI-anchored proteins involved in signaling and cell-cell communication, such as DAF and the neural cell adhesion molecule, diffuse freely on the cell surface, allowing these proteins to move rapidly in response to external stimuli (10) . To study the effects of the glycan core modifications on protein mobility, the diffusion kinetics of GFP-2, GFP-3, GFP-4, and the natively anchored GFP-GPIs on HeLa cell surfaces were investigated. Fluorescence recovery after photobleaching (FRAP), using total internal reflection fluorescence (TIRF) microscopy, was used to study the proteins' long-range diffusion and movement on the cell surface. Fluorescence correlation spectroscopy, (FCS) was then used to quantitatively assess and compare the mobilities of the different constructs.
After external loading of GFP-2, GFP-3, GFP-4, or transient expression of GFP-GPI(DAF) or GFP-GPI(FR), defined regions of the individual HeLa cells were first photobleached, and then the recovery of the fluorescence signal was imaged with TIRF microscopy. Rate analysis of GFP fluorescence recovery within the bleached area enabled an assessment of the modified proteins' mobilities (Fig. 4) . For all five proteins studied, fluorescence recovery occurred over tens of seconds, indicating that these proteins are membrane-associated and highly mobile on HeLa cell surfaces (Fig. 4) .
To more precisely assess the differences in mobility on this time scale, FCS measurements were performed on the cells incorporating the GFP variants. FCS provides an accurate measure of the average residence time of the GFP constructs within a small area of the cell surface (0.06 m 2 ). From these FCS measurements, the diffusion coefficient (D), a physical measure of protein mobility, can be calculated (47) . The higher the D, the faster the protein moves.
For each GFP construct, FCS measurements were performed on at least five individual HeLa cells. At each location within an individual cell, 10 separate correlation measurements of 30-s duration were acquired, and the corresponding standard deviations for every point of the experimental curves were calculated (Fig. 5A) . From these data, the characteristic diffusion correlation times ( D ) were determined and used to calculate D values for endogenously expressed GFP-GPI(DAF) and GFP-GPI(FR), as well as exogenously added GFP-2, GFP-3, and GFP-4, on the surface of HeLa cells (Fig. 5 B and C) . The D values for GFP-3 and GFP-4 were similar (P Ͼ 0.05), but were significantly lower than the D values for GFP-GPI(DAF) or GFP-GPI(FR) (P Յ 0.01). Interestingly, the D value calculated for GFP-2 was significantly lower than those for GFP-GPI(DAF) and GFP-GPI(FR) (P Ͻ 0.01) or GFP-3 and GFP-4 (P Ͻ 0.02).
Discussion
The system we developed enables the installation of synthetic GPI anchor analogs into cell surface proteins, followed by an analysis of their trafficking behavior and mobilities. Importantly, we demonstrated that proteins modified in vitro with synthetic GPI analogs can be inserted into cell membranes, where they traffic similarly to their native counterparts. Interestingly, GFP-2, which contains no monosaccharide units, incorporated onto all of the mammalian cells tested, suggesting that the sugars of the glycan core are unnecessary for membrane insertion and retention. However, cells treated with GFP-2 generally exhibited a lower fluorescence signal than cells treated with comparable amounts of GFP-3 or GFP-4. Thus, subtle differences in the efficiency of membrane insertion or retention may be engendered by alterations to the core structure.
With respect to intracellular trafficking, the GPI-protein analogs behaved similarly to natively anchored GFP-GPI in CHO cells, colocalizing with Tf-647, a marker of recycling endosomes. This result suggests that the glycan core structure is not a major determinant of endocytic fate. However, the lack of observed colocalization of GFP-GPI and Dex-647 does not agree with previous studies, which concluded that GFP-GPI(FR) is found in both recycling and early endosomes in CHO cells (15) . It is possible that the level of GFP-GPI(FR) in early endosomes was below our detection limit.
The first point of functional divergence among the synthetic and natural analogs was revealed in studies of their cell surface mobilities. FCS analysis revealed significantly lower diffusion kinetics for GFP-2, compared with GFP-3 and GFP-4 and the native GFP-GPIs. GFP-3 and GFP-4 also appeared to diffuse more slowly than their native counterparts. This trend in D values is similar to that previously observed for GFP-2, GFP-3, and GFP-4 in supported lipid bilayers (38) . In that study, the D value calculated for GFP-2 was lower than that for GFP-3, which in turn was lower than that for GFP-4. However, the D values for GFP-2, GFP-3, and GFP-4 in supported lipid bilayers were an order of magnitude higher than the D values for these constructs in cellular membranes (Fig. 5) (38) . These differences are likely because of interactions of the GPI-protein analogs with the plasma membrane and cell surface molecules, as well as the different composition of the cell membrane compared with the simple supported lipid bilayer. The variation in D values for the natively anchored GFPGPIs and the GPI-protein analogs suggests that the sugars of the glycan core can affect lateral mobility in the cell membrane. GFP-2 contains a highly f lexible hepta(ethylene glycol) linker as its GPI anchor substitute. The f lexible linker may permit greater movement of the attached protein, thus allowing the protein to engage in contacts with both the lipid bilayer and other cell surface proteins. Such transient interactions would be expected to retard diffusion. The additional sugar moieties in the anchors of GFP-3, GFP-4, and the native structures might sufficiently rigidify the anchors so as to avoid nonspecific membrane interactions.
. Selected images from FRAP experiments of individual HeLa cells at 25°C. (A) GFP-GPI(DAF) expressed in HeLa cells 27 h after transfection. (B) GFP-GPI(FR) expressed in HeLa cells 27 h after transfection. (C) GFP-2 on HeLa cells after a 4-h incubation. (D) GFP-3 on HeLa cells after a 4-h incubation. (E) GFP-4 on
The results of this study show that major deletions from the GPI glycan core can be made without affecting the endocytic fate of the attached protein, but that diffusion kinetics in the cell membrane are significantly altered. The synthetic platform established in this study can now be further expanded on with analogs bearing more subtly modified monosaccharide units, various side chain modifications, or lipid modifications. Moreover, because synthetic GPI analogs can be appended to a wide range of proteins, this chemical platform constitutes a powerful tool that now enables the systematic investigation of the biological functions of the GPI anchor. 
Methods
Incubation of Mammalian
Cell Transfection with GFP-GPI(DAF) or GFP-GPI(FR).
The pcDNA3-GFP-GPI(DAF) vector was a generous gift from D. Legler (University of Konstanz, Konstanz, Germany). The plasmid containing GFP-GPI(FR) was a generous gift from J. Lippincott-Schwartz (National Institute of Child Health and Human Development, Bethesda, MD). HeLa or CHO cells were transiently transfected with GFP-GPI(DAF) or GFP-GPI(FR) by using Lipofectamine (Invitrogen) and PLUS reagent (Invitrogen) according to the manufacturer's instructions. Cells were incubated at 37°C after transfection for 24 -48 h before being imaged or subjected to FRAP or FCS analyses.
Endocytosis of GFP-GPI(DAF), GFP-GPI(FR), GFP-2, GFP-3, GFP-4, Transferrin, and
Dextran. CHO cells were seeded on slides mounted with tissue culture wells (chambered no. 1.0 borosilicate coverglass system; Lab-Tek) at 30,000 -50,000 cells per milliliter and allowed to adhere for 12-16 h. CHO cells were transiently transfected with GFP-GPI(DAF) or GFP-GPI(FR) by using Lipofectamine and PLUS reagent according to the manufacturer's instructions. Cells were incubated at 37°C after transfection for 48 h before being rinsed five times with 1 ml of HAM F-12 nutrient mixture (Invitrogen), stained with 1 g/ml Hoechst 33342 dye (Invitrogen), and incubated with either 1 mg/ml dextran-Alexa Fluor 647 (10,000 MW; Invitrogen) for 5 min at 37°C or 50 g/ml transferrin-Alexa Fluor 647 (Invitrogen) for 30 min at 37°C. The cells were then rinsed five times with 1 ml of HAM F-12 and subjected to fluorescence microscopy. Alternatively, CHO cells were rinsed twice with 1 ml of PBS, and the media were replaced with 1 ml of serum-free HAM F-12 containing 10 g/ml GFP-Cys, GFP-2, GFP-3, or GFP-4. These cells were allowed to incubate at 37°C for 7-8 h, after which the cells were rinsed five times with 1 ml of HAM F-12, stained with 1 g/ml Hoechst 33342 dye, and incubated with either 1 mg/ml dextran-Alexa Fluor 647 for 5 min at 37°C or 50 g/ml transferrin-Alexa Fluor 647 for 30 min at 37°C. The cells were then rinsed five times with 1 ml of HAM F-12 and subjected to fluorescence microscopy at 25°C. Fluorescence images were acquired on a Zeiss Axiovert 200M inverted microscope (Carl Zeiss) equipped with a 63ϫ, 1.4 NA Plan-Apochromat oil immersion lens. A 175-W Xenon lamp housed in a Sutter DG4 illuminator linker to the microscope by an optical fiber was used for shuttering and illumination. Image stacks containing 20 -30 sections spaced 0.4 m apart were acquired by using a CoolSNAP HQ CCD camera (Photometrics). Slidebook software (Intelligent Imaging Innovations) was used to control the microscope and camera. The image stacks were digitally deconvolved by using the nearest neighbor algorithm of Slidebook.
TIRF-FRAP Measurements. HeLa cells were seeded on slides mounted with tissue culture wells at 10,000 -25,000 cells per milliliter and allowed to adhere for 12-16 h. HeLa cells were transiently transfected with GFP-GPI(DAF) or GFP-GPI(FR), incubated at 37°C after transfection for 24 -48 h, rinsed five times with 1 ml of DMEM (Invitrogen), and subjected to TIRF-FRAP analysis. Alternatively, HeLa cells were rinsed twice with 1 ml of PBS, and the media were replaced with 1 ml of serum-free DMEM containing 10 g/ml GFP-Cys, GFP-2, GFP-3, or GFP-4. These cells were allowed to incubate at 37°C for 4 h, after which the cells were rinsed five times with 1 ml of DMEM and subjected to TIRF-FRAP analysis at 25°C. TIRF-FRAP experiments were performed on an in-house-constructed TIRF microscope based on an inverted TE2000 microscope (Nikon). Images were taken with a 100ϫ, 1.45 NA TIRF oil immersion objective by using a 488-nm Argon Laser (Spectraphysics) for fluorophore excitation.
Photobleaching was performed by exposing a circular region (11 m in diameter) of a cell for 60 s to the evanescence wave (2.8 mW of laser power entering the objective). Pre-and postbleach images of the whole cell were acquired with the same TIRF settings.
FCS Measurements.
HeLa cells were seeded on slides mounted with tissue culture wells at 10,000 -30,000 cells per milliliter and allowed to adhere for 12-16 h. HeLa cells were transiently transfected with GFP-GPI(DAF) or GFP-GPI(FR) by using Lipofectamine and PLUS reagent according to the manufacturer's instructions. Cells were incubated at 37°C after transfection for 24 -48 h before being rinsed five times with 1 ml of DMEM and subjected to FCS analysis at 25°C. Alternatively, HeLa cells were rinsed twice with 1 ml of PBS, and the media were replaced with 1 ml of serum-free DMEM containing 20 g/ml GFP-Cys, GFP-2, GFP-3, or GFP-4. These cells were incubated at 37°C for 4 h, rinsed five times with 1 ml of DMEM, and subjected to FCS analysis at 25°C. FCS measurements were performed on an apparatus constructed in house (48) . At each measurement spot on a cell, 10 separate correlation curves of 30-s duration were acquired, and mean values and corresponding standard deviations for every point of the experimental curves were calculated. The average correlation curve was fitted to the theoretical curve describing free 2D diffu-
ͪͬ to obtain the characteristic correlation time, D . From the characteristic correlation time and the known laser spot size, 2 , the diffusion coefficient for each cell was calculated by using the equation D ϭ 2 /4D. The area of the laser spot was determined independently before and after each measurement series by using a 10 nM solution of 0.06-m 2 fluorescein. P values were calculated by using Student's t test.
